iShares Biotechnology ETF

Pfizer on Tuesday reported fiscal third-quarter results that topped estimates and hiked its full-year outlook, as…
Read More...

"This medicine could be one of our largest medicines in history," Novartis CEO Vas Narasimhan told CNBC on Tuesday,…
Read More...

Moderna gave investors a scare as its stock plunged on Thursday. But it's still one of the hottest biotechs this…
Read More...

Leaked confidential data. A major stock sell-off. Beneath the chaos surrounding Moderna and Merck's latest data on…
Read More...

Moderna shares dropped as much as 25% on Thursday following the leak of partial data on its closely watched cancer…
Read More...

AstraZeneca CEO Pascal Soriot told CNBC on Monday that Summit Therapeutics' lead drug could help power…
Read More...

Novartis has signed a deal worth up to $7.8 billion, in the latest of a flurry of tie-ups between Big Pharma and…
Read More...

The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines.Instead, drugmakers are…
Read More...

Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose of…
Read More...

The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersEvery time Novo urges investors to look ahead,…
Read More...